Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Andrews

Showing results (391-400 of 1,246) with videos related to

Pageof 125
Sort By:
Mutation Research|November 1, 1978
The mutagenicity of methyl orange and metabolites produced by intestinal anaerobesK T Chung, G E Fulk, A W Andrews
Mutation Research|August 1, 1979
Derivatives of side-chain hydroxylated nitrosamines direct acting mutagens in Salmonella typhimuriumC J Michejda, A W Andrews, S R Koepke
Expert Reviews in Molecular Medicine|September 9, 2010
Drugs targeting Bcl-2 family members as an emerging strategy in cancerBrian Leber, Fei Geng, Justin Kale, et al.
The Journal of Cell Biology|April 7, 1997
Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cellsA Rodríguez, P Webster, J Ortego, et al.
The Journal of Orthopaedic and Sports Physical Therapy|August 1, 1996
Walking speed: reference values and correlates for older adultsR W Bohannon, A W Andrews, M W Thomas
Journal of the National Cancer Institute|August 1, 1983
Effect of lithocholic acid on the mutagenicity of some substituted aromatic aminesJ C Kawalek, R K Hallmark, A W Andrews
Journal of the National Cancer Institute|October 1, 1976
Mutagenic activity of tryptophan metabolites produced by rat intestinal microfloraJ P Bowden, K T Chung, A W Andrews
American Journal of Obstetrics and Gynecology|May 20, 2000
Puerperal infection after cesarean delivery: evaluation of a standardized protocolC G Brumfield, J C Hauth, W W Andrews
Cancer Research|September 24, 1999
The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycanG Badcock, C Pigott, J Goepel, et al.
American Journal of Perinatology|July 27, 2002
Infection and preterm birthW W Andrews, J C Hauth, R L Goldenberg
Pageof 125

Showing results (391-400 of 1,246) with videos related to

Sort By:
Pageof 125
Mutation Research|November 1, 1978
The mutagenicity of methyl orange and metabolites produced by intestinal anaerobesK T Chung, G E Fulk, A W Andrews
Mutation Research|August 1, 1979
Derivatives of side-chain hydroxylated nitrosamines direct acting mutagens in Salmonella typhimuriumC J Michejda, A W Andrews, S R Koepke
Expert Reviews in Molecular Medicine|September 9, 2010
Drugs targeting Bcl-2 family members as an emerging strategy in cancerBrian Leber, Fei Geng, Justin Kale, et al.
The Journal of Cell Biology|April 7, 1997
Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cellsA Rodríguez, P Webster, J Ortego, et al.
The Journal of Orthopaedic and Sports Physical Therapy|August 1, 1996
Walking speed: reference values and correlates for older adultsR W Bohannon, A W Andrews, M W Thomas
Journal of the National Cancer Institute|August 1, 1983
Effect of lithocholic acid on the mutagenicity of some substituted aromatic aminesJ C Kawalek, R K Hallmark, A W Andrews
Journal of the National Cancer Institute|October 1, 1976
Mutagenic activity of tryptophan metabolites produced by rat intestinal microfloraJ P Bowden, K T Chung, A W Andrews
American Journal of Obstetrics and Gynecology|May 20, 2000
Puerperal infection after cesarean delivery: evaluation of a standardized protocolC G Brumfield, J C Hauth, W W Andrews
Cancer Research|September 24, 1999
The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycanG Badcock, C Pigott, J Goepel, et al.
American Journal of Perinatology|July 27, 2002
Infection and preterm birthW W Andrews, J C Hauth, R L Goldenberg
Pageof 125